3 completed, 1 recruiting. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 3, Recruiting 1 |
Follow Lumefantrine: new trials by email Literature Review of Lumefantrine trials Research Report on Lumefantrine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Southeast Asia Dose Optimization of Tafenoquine Tafenoquine, Chloroquine, Artemether 20 mg-Lumefantrine 120 mg - Plasmodium Vivax Malaria | Phase 4 | Recruiting | University of Oxford | 820 | 2024-07-22 | 2026-10-09 |
| Randomised Efficacy Study of Two Artemether-Lumefantrine Oral Formulations for the Treatment of Uncomplicated P. Falciparum Malaria Artemether/lumefantrine tablets, Artemether/Lumefantrine suspension - Malaria, Falciparum | Phase 4 | Completed | Dafra Pharma | 267 | 2007-05-01 | 2008-01-18 |
| ACT MALI: Treatment of Malaria Based on Combination Therapies Artesunate, Artesunate + Sulfadoxine-Pyrimethamine, arthemether + lumefantrine - Malaria | Phase 4 | Completed | Sanofi | 780 | 2005-07-01 | 2010-02-17 |
| Efficacy of Sulphadoxine-pyrimethamine and Artemisinin-containing Combination Therapy for Malaria Sulfadoxine-pyrimethamine, sulfadoxine-pyrimethamine plus artesunate, lumefantrine plus artemether - Malaria (Uncomplicated) | Phase 4 | Completed | Centers for Disease Control and Prevention | 390 | 2000-01-01 | 2012-09-11 |
Malaria (2) · Malaria, Falciparum (1) · Malaria, Vivax (1) · Recurrence (1)
Centers for Disease Control and Prevention (1) · Dafra Pharma (1) · Sanofi (1) · University of Oxford (1)
Cambodia (1) · Indonesia (1) · Kenya (1) · Laos (1) · Mali (1) · Tanzania (1) · Thailand (1) · Vietnam (1)
Cindy Chu, MD, PhD (1) · Elizabeth A Juma, Dr. (1) · John R MacArthur, MD, MPH (1) · Peter B Bloland, DVM, MPVM (1) · Salim Abdulla, MD, PhD (1)